Oncotarget

Research Papers:

Hemidesmus indicus induces immunogenic death in human colorectal cancer cells

Eleonora Turrini, Elena Catanzaro, Manuele G. Muraro, Valeria Governa, Emanuele Trella, Valentina Mele, Cinzia Calcabrini, Fabiana Morroni, Giulia Sita, Patrizia Hrelia, Massimo Tacchini and Carmela Fimognari _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:24443-24456. https://doi.org/10.18632/oncotarget.25325

Metrics: PDF 1055 views  |   HTML 1273 views  |   ?  


Abstract

Eleonora Turrini1,*, Elena Catanzaro1,*, Manuele G. Muraro2,*, Valeria Governa3, Emanuele Trella2, Valentina Mele3, Cinzia Calcabrini1, Fabiana Morroni4, Giulia Sita4, Patrizia Hrelia4, Massimo Tacchini5 and Carmela Fimognari1

1Department for Life Quality Studies, Alma Mater Studiorum–University of Bologna, Rimini, Italy

2Oncology Surgery, Department of Biomedicine, University Hospital of Basel and University of Basel, ZLF, Basel-Switzerland

3Cancer Immunotherapy, Department of Biomedicine, University Hospital of Basel and University of Basel, ZLF, Basel-Switzerland

4Department of Pharmacy and Biotechnology, Alma Mater Studiorum–University of Bologna, Bologna, Italy

5Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy

*These authors contributed equally to this work

Correspondence to:

Carmela Fimognari, email: carmela.fimognari@unibo.it

Keywords: Hemidesmus indicus; immunogenic cell death; adjuvant activity; botanical drugs; colorectal cancer

Received: July 29, 2017     Accepted: April 16, 2018     Published: May 11, 2018

ABSTRACT

The ability of anticancer treatments to promote the activation of tumor-reactive adaptive immune responses is emerging as a critical requirement underlying their clinical effectiveness. We investigated the ability of Hemidesmus indicus, a promising anticancer botanical drug, to stimulate immunogenic cell death in a human colorectal cancer cell line (DLD1). Here we show that Hemidesmus treatment induces tumor cell cytotoxicity characterized by surface expression of calreticulin, increased HSP70 expression and release of ATP and HMGB1. Remarkably, the exposure to released ICD-inducer factors from Hemidesmus-treated DLD1 cells caused a modest induction of CD14-derived dendritic cells maturation, as demonstrated by the increased expression of CD83. Moreover, at sub-toxic concentrations, H.i. treatment of monocytes and dendritic cells induced their mild activation, suggesting its additional direct immunostimulatory activity. These data indicate that Hemidesmus indicus induces immunogenic cell death in human tumor cells and suggest its potential relevance in innovative cancer immunotherapy protocols.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25325